▮Table 3▮.

Comparison of GS-1 and GS-2 in Cases Not Demonstrating TCR-Vβ Restriction^*

Diagnosis/Case No.	T Cells in GS−1 Negative f or All Vp Tested (%)	T Cells in GS−2 Negative for All Vp Tested (%)	Clonality by TCR PCR
ATLL
1	90.76	†	+
2	61.06	73.4	+
4	83.05	86.76	+
5	89.79	90.16	+
9	98.6	99.03	+
13	78.64	92.79	+
18	95.26	97.49	+
20	52.46	71.65	+
23	71.81	82.63	+
CTCL
25	81.44	‡	+
27	94.4	†	ND
LGL
37	71.55	†	+
38	90.02	95.5	ND
41	70.56	‡	+

ATLL, human T-lymphotropic virus-1–associated adult T-cell leukemia/lymphoma; CTCL, cutaneous T-cell lymphoma; GS, gating strategy; LGL, T-cell large granular lymphocytic leukemia; ND, not done; PCR, polymerase chain reaction; TCR, T-cell receptor; +, clonal rearrangement detected.

^*Mean (range) for GS-1, 80.7% (52.46%−98.6%); and for GS-2, 87.7% (71.65%−99.03%).

^†All CD4+ or CD8+ T cells are tumor, and GS-2 not different from GS-1.

^‡No aberrancy in T-cell antigen expression detected, and GS-2 is not applicable.